The first report from the 100,000 Genomes Cancer Program, consisting of an analysis of whole-genome sequencing from 13,800 solid tumours was recently published in Nature Medicine. As discussed in the report, comprehensive tumour profiling "will enable further refinement of prognostic and predictive molecular markers, not only with combinations of different genomic alterations, but beyond genomics, including emerging technologies to expand the reach of precision oncology to improve cancer outcomes."
To learn more about the 100,000 genomes project, click here.
Source mentioned:
Sosinsky A., Ambrose J, Cross W, et al. Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer Programme. Nature Medicine; Published online 11 January 2024. DOI: https://doi.org/10.1038/s41591-023-02682-0
No comments:
Post a Comment